Thematic minireview series on phospholipase D and cancer
Julian Gomez-Cambronero1, George M Carman2
1Department of Biochemistry and Molecular Biology, Wright State University School Medicine, Dayton, Ohio 45435 and.
Abstract:
Phospholipase D (PLD) signaling plays a critical role in cell growth and proliferation, vesicular trafficking, secretion, and endocytosis. At the cellular level, PLD and its reaction product, phosphatidate, interact with a large number of protein partners that are directly related to the actin cytoskeleton and cell migration. Cancer invasion and metastasis rely heavily on cellular motility, and as such, they have put PLD at center stage in cancer research. This minireview series highlights some of the molecular mechanisms that provide evidence for the emerging tumorigenic potential of PLD, the role of the microenvironment, and putative connections with inflammation. PLD represents a potential target for the rational development of therapeutics against cancer and other diseases.
Insights
Phospholipase D (PLD) signaling is crucial for cell functions and migration. Emerging evidence links PLD to cancer, highlighting its potential as a therapeutic target for various diseases.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Phospholipase D (PLD) signaling is integral to fundamental cellular processes including growth, proliferation, and vesicular transport.
- PLD and its product, phosphatidate, directly influence the actin cytoskeleton and cellular migration.
- Cellular motility is a key driver of cancer invasion and metastasis, positioning PLD as a significant factor in cancer research.
Discussion:
- This review series explores the molecular mechanisms underlying PLD's emerging role in tumorigenesis.
- The influence of the tumor microenvironment on PLD activity and cancer progression is examined.
- Potential links between PLD signaling and inflammatory pathways in cancer are discussed.
Key Insights:
- PLD signaling pathways are implicated in promoting cancer cell motility and invasion.
- The tumor microenvironment modulates PLD activity, affecting cancer cell behavior.
- PLD's involvement in inflammation suggests a multifaceted role in cancer development.
Outlook:
- PLD represents a promising molecular target for novel anti-cancer therapeutic strategies.
- Understanding PLD signaling may lead to treatments for other diseases beyond cancer.
- Further research into PLD's interactions could unlock new avenues for drug development.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
IP3/DAG Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes


